April 22, 2018 / 3:07 PM / 3 months ago

Fresenius Medical cuts 2018 sales target after drug dosage shift

BERLIN, April 22 (Reuters) - German dialysis specialist Fresenius Medical Care cut its 2018 sales target after a reduction in the dosing of calcimimetic drugs in the United States.

The company said on Sunday it now expects sales to rise by 5-7 percent at constant currency, compared with a previous forecast for a rise of around 8 percent.

It confirmed a target for net income to rise by 13-15 percent at constant currency.

Reporting by Victoria Bryan, editing by David Evans

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below